133 related articles for article (PubMed ID: 26216699)
21. Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.
Frulio N; Balabaud C; Laurent C; Trillaud H; Bioulac-Sage P
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):e63-e67. PubMed ID: 31047837
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for bleeding in hepatocellular adenoma.
Bieze M; Phoa SS; Verheij J; van Lienden KP; van Gulik TM
Br J Surg; 2014 Jun; 101(7):847-55. PubMed ID: 24760723
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
[TBL] [Abstract][Full Text] [Related]
25. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.
Reddy SK; Kishnani PS; Sullivan JA; Koeberl DD; Desai DM; Skinner MA; Rice HE; Clary BM
J Hepatol; 2007 Nov; 47(5):658-63. PubMed ID: 17637480
[TBL] [Abstract][Full Text] [Related]
26. Management of patients with hepatocellular adenoma: a single-institution experience.
Nahm CB; Parker N; Gundara JS; Gill AJ; Bhimani N; Samra JS; Hugh TJ
ANZ J Surg; 2020 May; 90(5):786-790. PubMed ID: 31943651
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients.
Rhim H; Lim HK; Kim YS; Choi D
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e422-7. PubMed ID: 17944897
[TBL] [Abstract][Full Text] [Related]
28. Systematic review of transarterial embolization for hepatocellular adenomas.
van Rosmalen BV; Coelen RJS; Bieze M; van Delden OM; Verheij J; Dejong CHC; van Gulik TM
Br J Surg; 2017 Jun; 104(7):823-835. PubMed ID: 28518415
[TBL] [Abstract][Full Text] [Related]
29. Management of ruptured hepatocellular adenoma.
Huurman VA; Schaapherder AF
Dig Surg; 2010; 27(1):56-60. PubMed ID: 20357452
[TBL] [Abstract][Full Text] [Related]
30. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study.
Karlsson J; Taft C; Rydén A; Sjöström L; Sullivan M
Int J Obes (Lond); 2007 Aug; 31(8):1248-61. PubMed ID: 17356530
[TBL] [Abstract][Full Text] [Related]
31. Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
Bioulac-Sage P; Sempoux C; Frulio N; Le Bail B; Blanc JF; Castain C; Laurent C; Trillaud H; Chiche L; Balabaud C
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):12-19. PubMed ID: 30213653
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostics and treatment of hepatocellular adenomas].
Klompenhouwer AJ; de Man RA; Thomeer MG; Doukas M; IJzermans JN
Ned Tijdschr Geneeskd; 2016; 160():D556. PubMed ID: 27650020
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
34. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization.
Stoot JH; van der Linden E; Terpstra OT; Schaapherder AF
Br J Surg; 2007 Oct; 94(10):1249-53. PubMed ID: 17696216
[TBL] [Abstract][Full Text] [Related]
35. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
Ott R; Hohenberger W
Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
[TBL] [Abstract][Full Text] [Related]
36. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study.
Haring MPD; Gouw ASH; de Haas RJ; Cuperus FJC; de Jong KP; de Meijer VE
Liver Int; 2019 May; 39(5):905-913. PubMed ID: 30773766
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
38. Evidence of good prognosis of hepatocellular adenoma in post-menopausal women.
Klompenhouwer AJ; Sprengers D; Willemssen FE; Gaspersz MP; Ijzermans JN; De Man RA
J Hepatol; 2016 Dec; 65(6):1163-1170. PubMed ID: 27524464
[TBL] [Abstract][Full Text] [Related]
39. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
40. [Hepatocellular adenoma - new classification and recommendations].
Aamann L; Schultz N; Fallentin E; Hamilton-Dutoit S; Vogel I; Grønbæk H
Ugeskr Laeger; 2015 Mar; 177(12):V07140397. PubMed ID: 25786843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
